Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Protalix BioTherapeutics (PLX) Institutional Ownership

Protalix BioTherapeutics logo
$2.04 +0.03 (+1.44%)
Closing price 03:59 PM Eastern
Extended Trading
$2.03 -0.01 (-0.64%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)

Current
Institutional Ownership
Percentage
16.53%
Number of
Institutional Buyers
(last 12 months)
35
Total
Institutional Inflows
(last 12 months)
$5.95M
Number of
Institutional Sellers
(last 12 months)
10
Total
Institutional Outflows
(last 12 months)
$656.29K
Get PLX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PLX Institutional Buying and Selling by Quarter

Protalix BioTherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE79,079$172K0.0%+70.6%0.098%
5/16/2026 Lazard Asset Management LLC86,617$188K0.0%+21.3%0.108%
5/14/2026 Renaissance Technologies LLC1,224,800$2.66M0.0%-3.0%1.520%
5/7/2026 Dimensional Fund Advisors LP296,843$644K0.0%+932.7%0.368%
5/5/2026 Bank of New York Mellon Corp219,307$476K0.0%+4.0%0.272%
2/19/2026 Invesco Ltd.50,563$91K0.0%+12.4%0.063%
2/18/2026 XTX Topco Ltd34,296$62K0.0%-60.0%0.043%
2/18/2026 Opaleye Management Inc.2,478,176$4.46M0.6%-4.0%3.082%
2/18/2026Main Street Financial Solutions LLC214,100$385K0.0%+65.8%0.266%
2/17/2026 Lazard Asset Management LLC71,393$129K0.0%N/A0.089%
2/16/2026 Barclays PLC112,849$203K0.0%+10.9%0.140%
2/13/2026 Marshall Wace LLP19,079$34K0.0%N/A0.024%
2/13/2026 The Manufacturers Life Insurance Company 18,498$33K0.0%-23.1%0.023%
2/13/2026 Smartleaf Asset Management LLC25,975$45K0.0%N/A0.032%
2/13/2026 State Street Corp585,261$1.05M0.0%+17.4%0.728%
2/13/2026 Wells Fargo & Company MN79,002$142K0.0%+84.5%0.098%
2/12/2026 Jane Street Group LLC289,917$522K0.0%-894.3%0.360%
2/12/2026 HRT Financial LP64,610$116K0.0%N/A0.080%
2/12/2026 Renaissance Technologies LLC1,263,300$2.27M0.0%-4.0%1.571%
2/12/2026 Dimensional Fund Advisors LP28,744$51K0.0%+68.8%0.036%
2/12/2026 New York State Common Retirement Fund31,100$56K0.0%-24.7%0.039%
2/10/2026 Goldman Sachs Group Inc.262,809$473K0.0%+74.2%0.327%
2/9/2026 Geode Capital Management LLC830,054$1.49M0.0%+1.3%1.032%
1/30/2026 R Squared Ltd14,632$26K0.0%N/A0.018%
1/27/2026 Round Rock Advisors LLC155,102$279K0.0%N/A0.193%
1/23/2026 State of Alaska Department of Revenue21,831$39K0.0%N/A0.027%
1/9/2026 SG Americas Securities LLC17,155$31K0.0%N/A0.021%
11/17/2025 Prelude Capital Management LLC49,791$111K0.0%-11.2%0.062%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.32,253$72K0.0%-15.3%0.040%
11/14/2025 Virtu Financial LLC16,530$37K0.0%N/A0.021%
11/13/2025 BNP Paribas Financial Markets15,215$34K0.0%+126.5%0.019%
11/12/2025 Dimensional Fund Advisors LP17,028$38K0.0%-62.6%0.021%
11/12/2025 Intech Investment Management LLC31,248$69K0.0%-14.4%0.039%
11/6/2025 Rhumbline Advisers65,194$145K0.0%-6.6%0.082%
11/6/2025 Stratos Wealth Partners LTD.500,000$1.11M0.0%+42.9%0.627%
11/4/2025 State of Wyoming39,018$87K0.0%N/A0.049%
11/3/2025 New York State Common Retirement Fund41,300$92K0.0%-40.1%0.052%
8/16/2025 Evergreen Capital Management LLC171,338$254K0.0%N/A0.215%
8/15/2025 Bank of America Corp DE21,892$32K0.0%+364,766.7%0.028%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.38,075$56K0.0%N/A0.048%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
8/13/2025 Diametric Capital LP143,272$212K0.1%N/A0.180%
8/13/2025 Invesco Ltd.45,141$67K0.0%N/A0.057%
8/13/2025 New York State Common Retirement Fund69,000$102K0.0%N/A0.087%
8/12/2025 XTX Topco Ltd73,675$109K0.0%+76.1%0.093%
8/12/2025 JPMorgan Chase & Co.34,545$51K0.0%+2,065.8%0.043%
8/8/2025 Intech Investment Management LLC36,490$54K0.0%N/A0.046%
8/8/2025 Police & Firemen s Retirement System of New Jersey18,554$27K0.0%N/A0.023%
8/8/2025 Geode Capital Management LLC826,333$1.22M0.0%N/A1.038%
8/7/2025 Cascade Financial Partners LLC17,000$25K0.0%N/A0.021%
8/7/2025 Connor Clark & Lunn Investment Management Ltd.496,216$734K0.0%+2.8%0.623%
8/5/2025 Harel Insurance Investments & Financial Services Ltd.26,000$40K0.0%N/A0.033%
7/29/2025 Orin Green Financial LLC61,200$91K0.0%+22.4%0.077%
6/27/2025 Goldman Sachs Group Inc.289,461$741K0.0%+482.3%0.364%
5/19/2025Jane Street Group LLC294,318$753K0.0%+159.0%0.370%
5/16/2025Goldman Sachs Group Inc.289,461$741K0.0%+482.3%0.364%
5/16/2025NewEdge Advisors LLC15,080$39K0.0%N/A0.019%
5/15/2025Cubist Systematic Strategies LLC53,380$137K0.0%+82.1%0.067%
5/15/2025OMERS ADMINISTRATION Corp179,300$459K0.0%N/A0.225%
5/14/2025Hsbc Holdings PLC25,535$64K0.0%-36.2%0.032%
5/12/2025Connor Clark & Lunn Investment Management Ltd.482,875$1.24M0.0%N/A0.607%
5/8/2025XTX Topco Ltd41,826$107K0.0%N/A0.053%
5/8/2025GSA Capital Partners LLP209,292$536K0.0%-31.5%0.263%
5/6/2025Orin Green Financial LLC50,000$128K0.1%-30.6%0.063%
4/30/2025Stratos Wealth Partners LTD.346,400$887K0.0%+28.3%0.444%
2/17/2025Squarepoint Ops LLC73,940$139K0.0%+33.4%0.100%
2/17/2025Point72 Asia Singapore Pte. Ltd.53,507$101K0.0%+13.7%0.073%
2/17/2025Millennium Management LLC387,921$729K0.0%+3.8%0.527%
2/17/2025Cubist Systematic Strategies LLC29,307$55K0.0%+24.1%0.040%
2/17/2025Bank of America Corp DE33,714$63K0.0%-25.1%0.046%
2/14/2025Jane Street Group LLC113,616$214K0.0%+147.2%0.154%
2/14/2025Northern Trust Corp731,742$1.38M0.0%+1,299.4%0.994%
2/13/2025Marshall Wace LLP101,899$192K0.0%N/A0.138%
2/13/2025Renaissance Technologies LLC1,118,000$2.10M0.0%+17.0%1.518%
2/11/2025Prudential Financial Inc.36,400$68K0.0%N/A0.049%
2/11/2025Virtu Financial LLC34,276$64K0.0%-21.0%0.047%
2/4/2025Y Intercept Hong Kong Ltd18,818$35K0.0%N/A0.026%
1/22/2025PFG Investments LLC20,730$39K0.0%N/A0.028%
11/25/2024Sanctuary Advisors LLC37,100$38K0.0%N/A0.050%
11/20/2024Virtu Financial LLC43,388$44K0.0%N/A0.059%
11/15/2024XTX Topco Ltd35,058$36K0.0%N/A0.048%
11/15/2024Jane Street Group LLC45,952$47K0.0%-84.2%0.062%
11/15/2024Point72 Asia Singapore Pte. Ltd.47,073$48K0.0%-30.9%0.064%
11/5/2024GSA Capital Partners LLP435,213$444K0.0%+8.5%0.592%
9/16/2024Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044%
9/16/2024Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093%
8/15/2024AQR Capital Management LLC57,106$67K0.0%N/A0.078%
8/15/2024Point72 Asia Singapore Pte. Ltd.68,163$80K0.0%N/A0.093%
8/14/2024Squarepoint Ops LLC137,764$161K0.0%+673.3%0.188%
8/14/2024Cubist Systematic Strategies LLC32,031$37K0.0%N/A0.044%
8/9/2024Renaissance Technologies LLC804,600$941K0.0%-2.4%1.097%
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
8/8/2024Ground Swell Capital LLC62,234$73K0.1%N/A0.085%
5/20/2024Virtu Financial LLC157,516$198K0.0%N/A0.215%
5/7/2024SG Americas Securities LLC21,467$27K0.0%-38.0%0.029%
5/3/2024GSA Capital Partners LLP493,571$622K0.0%-9.3%0.673%
2/2/2024Bailard Inc.68,100$121K0.0%N/A0.095%
1/19/2024Denali Advisors LLC94,700$169K0.1%-14.1%0.132%
11/15/2023GSA Capital Partners LLP496,781$825K0.1%N/A0.694%
11/13/2023Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234%
11/7/2023Barclays PLC46,511$77K0.0%+251.6%0.065%
10/27/2023Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193%


PLX Institutional Ownership - Frequently Asked Questions

During the previous two years, 55 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were Opaleye Management Inc. ($4.46M), Renaissance Technologies LLC ($2.66M), Geode Capital Management LLC ($1.49M), Northern Trust Corp ($1.38M), Stratos Wealth Partners LTD. ($1.11M), State Street Corp ($1.05M), and Connor Clark & Lunn Investment Management Ltd. ($734K).Learn more on Protalix BioTherapeutics' institutional investors.

16.53% of Protalix BioTherapeutics' stock is owned by institutional investors. Learn more on PLX's institutional investor holdings.

Of the 50 institutional investors that purchased Protalix BioTherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($836.61K), Northern Trust Corp ($679.45K), Goldman Sachs Group Inc. ($591.48K), Jane Street Group LLC ($574.78K), Connor Clark & Lunn Investment Management Ltd. ($496.22K), Dimensional Fund Advisors LP ($279.82K), and Stratos Wealth Partners LTD. ($226.40K).

Institutional investors have bought a total of 3,355,379 shares in the last 24 months. This purchase volume represents approximately $5.95M in transactions.

Of the 10 institutional investors that sold Protalix BioTherapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Opaleye Management Inc. ($102.38K), Renaissance Technologies LLC ($90.60K), XTX Topco Ltd ($51.55K), New York State Common Retirement Fund ($37.90K), Dimensional Fund Advisors LP ($28.54K), Prelude Capital Management LLC ($6.26K), and MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. ($5.82K).

Institutional investors have sold a total of 338,454 shares in the last 24 months. This volume of shares sold represents approximately $656.29K in transactions.



This page (NYSE:PLX) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners